On 9th July 2025, a meeting was held with the Executive Director, JPMC to discuss expanding Thalassemia services, training and referral for CVS, support for bleeding disorder patients, and implementation of Hemovigilance. The discussion reflected a shared commitment to strengthening patient care and transfusion safety.
